Quick Answer: Retatrutide is an investigational weight loss drug from Eli Lilly that targets three hormone receptors (GLP-1, GIP, and glucagon) one more than Mounjaro and two more than Ozempic
My Hands-On Mochi Experience For my review, I tested and scored Mochi Health across six key areas that matter most: true cost, legitimacy, patient support, shipping standards, transparency, and real customer feedback
Microdosing means using well-below-standard starting doses of a GLP1 agonist to gain metabolic and neurologic benefits while minimizing side effects
Research use only: what it means in practice Research-grade retatrutide is sold exclusively for laboratory and research use
However, emerging human data have not shown an increased risk of major birth defects when GLP-1s were used during early pregnancy
These conditions cause fatigue independently and compound the metabolic adjustment fatigue from retatrutide